US to build 2 more maximum security infectious disease labs
In the wake of the September 11 attacks, the US Department of Health is pushing ahead with plans to build at least five maximum security laboratories to study deadly diseases like Ebola, anthrax and smallpox. Five of these “level 4” labs already exist in the US. The government feels that the labs are essential in the war on terror. “To know that we can do this research and not do it would be irresponsible,” says Rona Hirschberg, of the National Institutes of Health.
A lab in Boston has drawn fierce opposition from community activists — and even from 150 scientists, including two Nobel laureates from Harvard. They query whether housing dangerous pathogens in an urban setting is safe. “There’s no way of having a system that’s 100% foolproof,” said Penn Loh, executive director of Alternatives for Community and Environment in Roxbury, an inner city, mainly black, Boston neighbourhood near the site. “Should something occur, you don’t want it to happen in a densely populated area.”
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...